Pharmacodynamic studies of voriconazole: informing the clinical management of invasive fungal infections.

@article{Job2016PharmacodynamicSO,
  title={Pharmacodynamic studies of voriconazole: informing the clinical management of invasive fungal infections.},
  author={Kathleen M Job and Jared A Olson and Chris Stockmann and Jonathan E. Constance and Elena Yu Enioutina and Joseph E Rower and Matthew W Linakis and Alan L Balch and Tian Yu and Xiaoxi Liu and Emily Thorell and Catherine M T Sherwin},
  journal={Expert review of anti-infective therapy},
  year={2016},
  volume={14 8},
  pages={
          731-46
        }
}
INTRODUCTION Voriconazole is a broad-spectrum antifungal agent commonly used to treat invasive fungal infections (IFI), including aspergillosis, candidiasis, Scedosporium infection, and Fusarium infection. IFI often occur in immunocompromised patients, leading to increased morbidity and mortality. AREAS COVERED The objective of this review is to summarize the pharmacodynamic properties of voriconazole and to provide considerations for potential optimal dosing strategies. Studies have… CONTINUE READING
1
Twitter Mention

Citations

Publications citing this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 202 REFERENCES

Achieving target voriconazole concentrations more accurately in children and adolescents.

  • Antimicrobial agents and chemotherapy
  • 2015
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Genetic susceptibility to Candida infections

SP Smeekens, FL van de Veerdonk, BJ Kullberg, MG. Netea
  • EMBO Mol Med
  • 2013
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).

  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2010
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Therapeutic drug monitoring of voriconazole.

  • Therapeutic drug monitoring
  • 2008
VIEW 11 EXCERPTS
HIGHLY INFLUENTIAL